Advertisement
Screener

NOVA LTD. (NVMI) Spending and interest coverage

NOVA LTD. (NVMI) Spending and interest coverage

  • R&D / revenue · 12 months: Value 16.28%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
  • Stock-based compensation / revenue · 12 months: Value 2.99%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months16.28%Research and development expense / revenue. Period ending 2025-12-31.

$143.39M ÷ $880.58M × 100 ≈ 16.28%

Stock-based compensation / revenue · 12 months2.99%Share-based compensation / revenue. Period ending 2025-12-31.

$26.29M ÷ $880.58M × 100 ≈ 2.99%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending143.39M USDResearch and Development Expense
Revenue880.58M USD
Stock-based compensation26.29M USDShare-based Payment Arrangement, Noncash Expense
Operating income253.47M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2025-12-31$143.39M$880.58M$26.29M$253.47M(m)16.28%2.99%(m)(m)
2025-06-30$128.67M$807.09M$25.18M$233.58M(m)15.94%3.12%(m)(m)
2024-12-31$110.26M$672.40M$25.21M$187.54M(m)16.40%3.75%(m)(m)
2024-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31$88.04M$517.92M$18.29M$132.26M(m)17.00%3.53%(m)(m)
2022-12-31$90.46M$570.73M$16.65M$149.93M(m)15.85%2.92%(m)(m)
2021-12-31$65.86M$416.11M$10.49M$112.39M(m)15.83%2.52%(m)(m)
2020-12-31$53.02M$269.40M$6.95M$55.57M(m)19.68%2.58%(m)(m)
2019-12-31$44.51M$224.91M$5.09M$36.41M(m)19.79%2.26%(m)(m)
2018-12-31$45.45M$251.13M$4.33M$60.44M(m)18.10%1.72%(m)(m)
2017-12-31$38.96M$221.99M$2.78M$57.82M(m)17.55%1.25%(m)(m)
2016-12-31$35.00M$163.90M$2.73M$10.17M(m)21.35%1.67%(m)(m)
2015-12-31$39.70M$148.51M$2.67M$11.58M(m)26.73%1.80%(m)(m)
2014-12-31$29.50M$120.62M$2.12M$16.91M(m)24.46%1.76%(m)(m)
2013-12-31$29.58M$111.51M$2.10M$12.33M(m)26.53%1.88%(m)(m)
2012-12-31$24.59M$96.17M$1.93M$10.58M(m)25.57%2.00%(m)(m)
2011-12-31$18.68M$102.83M$1.44M$24.72M(m)18.16%1.40%(m)(m)
2010-12-31$12.45M$86.62M$710.00K$21.87M(m)14.37%0.82%(m)(m)
2009-12-31$6.87M$39.32M$454.00K$2.47M(m)17.46%1.15%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.